11/01/2019 15:00:00

Hershey to Webcast Fourth-Quarter Conference Call

HERSHEY, Pa., Jan. 11, 2019 (GLOBE NEWSWIRE) -- The Hershey Company (NYSE:HSY) announced today that it will release its fourth-quarter sales and earnings results on Thursday, January 31, 2019, and hold a conference call with analysts at 8:30 a.m. ET on that date.

Investors and analysts may participate via phone by calling 1-866-342-8591 in the United States and 1-203-518-9797 from all other locations and referencing the conference ID THC4Q18.  To ensure timely access, participants should dial in approximately 10 minutes before the conference call begins.

The conference call will be available and can be replayed for 14 business days and can be accessed by dialing 1-800-723-2156 in the United States (1-402-220-2660 for international callers) and using the Hershey conference ID THC4Q18.

A listen-only webcast will be provided via The Hershey Company website. Please click here and navigate to “CALENDAR OF EVENTS” for webcast details.

If you are unable to click on the link above, please copy and paste the URL below into a web browser

https://www.thehersheycompany.com/content/corporate_SSF/en_us/investors/events-reports-releases/calendar-of-events.html

FINANCIAL CONTACT:

   

MEDIA CONTACT:

Melissa Poole   Jeff Beckman
717-534-7556   717-534-8090

The Hershey Company

Related content
30 May - 
The Hershey Company partners with Singer-Songwriter, La..
20 May - 
Hershey Showcases 125 Years of Brand Relevance at 2019 ..
15 May - 
Hershey’s Unwrapped to Open This Month at Hershey’s Cho..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Forty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma
2
REV DEADLINE: Rosen, a Highly Ranked Law Firm, Reminds Revlon, Inc. Investors of Important July 15th Deadline in Securities Class Action – REV
3
Editas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell Disease and Beta-Thalassemia at the 24th Congress of the European Hematology Association
4
FSIS Recall 069-2019 Foreign Matter Contamination: RUIZ FOODS PRODUCTS INC. RECALLS BACON BREAKFAST WRAP PRODUCTS DUE TO POSSIBLE FOREIGN MATTER CONTAMINATION
5
Apellis Pharmaceuticals Presents Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at 24th European Hematology Association (EHA) Congress

Related stock quotes

The Hershey Company 138.32 0.5% Stock price increasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
16 June 2019 04:28:24
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB6 - 2019-06-16 05:28:24 - 2019-06-16 04:28:24 - 1000 - Website: OKAY